These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13953367)

  • 1. The control of phenylindanedione treatment.
    HEIKINHEIMO R
    Acta Med Scand; 1963 Jun; 173():671-81. PubMed ID: 13953367
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of ACTH on prothrombin-proconvertin values in blood during treatment with dicumarol and phenylindanedione.
    HELLEM AJ; SOLEM JH
    Acta Med Scand; 1954; 150(5):389-93. PubMed ID: 13217736
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of phenylindanedione on the coagulation factors prothrombin, factor V and factor VII and the question of vitamin K resistance].
    PERLICK E
    Klin Wochenschr; 1953 Mar; 31(11-12):261-3. PubMed ID: 13070456
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effects of phenylindanedione on blood coagulation].
    CASULA D
    Rass Med Sarda; 1955; 57(3-4):153-62. PubMed ID: 13290063
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect on different clotting factors of short-term treatment with phenylindanedione.
    EGEBERG O
    Scand J Clin Lab Invest; 1962; 14():247-52. PubMed ID: 13889406
    [No Abstract]   [Full Text] [Related]  

  • 6. The mode of action of phenylindanedione.
    WALKER W; HUNTER RB
    J Clin Pathol; 1954 Aug; 7(3):249-51. PubMed ID: 13192203
    [No Abstract]   [Full Text] [Related]  

  • 7. [THE ANTICOAGULANT PROPERTIES OF DIPHENAZIN].
    KONIUKHOV SG
    Vopr Med Khim; 1964; 10():192-7. PubMed ID: 14231608
    [No Abstract]   [Full Text] [Related]  

  • 8. HALOPERIDOL AND ANTICOAGULANT TREATMENT.
    OAKLEY DP; LAUTCH H
    Lancet; 1963 Dec; 2(7319):1231. PubMed ID: 14072965
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of 2-phenyl-1-3-diketohydrindene on blood coagulation].
    SCHMID J; VINAZZER H
    Wien Z Inn Med; 1953 May; 34(5):194-9. PubMed ID: 13090767
    [No Abstract]   [Full Text] [Related]  

  • 10. LABORATORY CONTROL OF ANTICOAGULANT THERAPY.
    LAU KS; SINGH N
    Med J Malaya; 1963 Dec; 18():107-15. PubMed ID: 14117278
    [No Abstract]   [Full Text] [Related]  

  • 11. A new prothrombopenic drug, phenylindanedione.
    JAQUES LB; GORDON E LEPP E
    Can Med Assoc J; 1950 May; 62(5):465-70. PubMed ID: 15411629
    [No Abstract]   [Full Text] [Related]  

  • 12. A one stage method for the assay of antihemophilic factor B (AHF B) with a comment on the antihemophilic factor B (AHF B) concentration in phenylindanedione (PID) therapy.
    STAPP WF
    Scand J Clin Lab Invest; 1958; 10(2):169-76. PubMed ID: 13602673
    [No Abstract]   [Full Text] [Related]  

  • 13. Heparin resistance determined by the heparin tolerance test in patients treated with phenylindanedione before, during, and after operation.
    GORMSEN J; HAXHOLDT BF
    Acta Chir Scand; 1961; 121():367-76. PubMed ID: 13707283
    [No Abstract]   [Full Text] [Related]  

  • 14. The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin.
    TAGER M
    Yale J Biol Med; 1953 Apr; 25(5):374-82. PubMed ID: 13057268
    [No Abstract]   [Full Text] [Related]  

  • 15. [Research on anticoagulant effect of phenylindanedione and its relation to the substances with vitamin P effect].
    LONGO G
    Haematologica; 1954; 38(9):1161-8. PubMed ID: 13221125
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.
    FICHERA C
    Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019
    [No Abstract]   [Full Text] [Related]  

  • 17. ADMINISTRATION AND CONTROL OF ANTICOAGULANT TREATMENT.
    POLLER L
    Manch Med Gaz; 1964; 43():8-11. PubMed ID: 14125255
    [No Abstract]   [Full Text] [Related]  

  • 18. INITIAL EXPERIENCE WITH THROMBOTEST.
    MILLER AL; FARRER-BROWN G; PETHER J
    J Clin Pathol; 1964 Mar; 17(2):182-4. PubMed ID: 14149946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EFFECT OF ANTICOAGULANT DRUGS ON PLATELET AGGREGATION IN THE CHANDLER'S TUBE.
    CUNNINGHAM GM; MCNICOL GP; DOUGLAS AS
    Lancet; 1965 Apr; 1(7388):729-30. PubMed ID: 14255241
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anticoagulant and hemostatic therapy in obstetrics and gynecology. I. Phenylindanedione].
    STURA L; CRAVAREZZA F
    Quad Clin Ostet Ginecol; 1955 Jul; 10(7):409-26. PubMed ID: 13266979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.